Pfizer, NicOx Eye Treatment Trial Falls Short (PharmaceuticalOnline)

A Phase II trial from Pfizer and its partner NicOx failed to meet its primary endpoint in studying PF 03187207 in patients with primary open-angle glaucoma or ocular hypertension.

My Pharmiweb.com (PharmiWeb)

NicOx S.A. (Euronext Paris: COX) today announced the results of a dose-ranging phase 2 study conducted with PF¬03187207 in Japanese patients with glaucoma by its partner Pfizer Inc. PF-03187207 is a nitric oxide-donating prostaglandin analog.

US Pharmacies Now Supply ADHD Medication VYVANSE In 6 Dosage Strengths (Medical News Today)

Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, has announced that VYVANSE is now available in U.S. pharmacies nationwide in three additional dosage strengths, bringing the total number to six: 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg. The expanded VYVANSE dosing options will allow physicians to individualize treatment for each patient.

Medication Slows Progression Of Myopia In Children (Medical News Today)

Daily treatment with a medication called pirenzepine can slow the rate of progressive myopia, or nearsightedness, in children, reports a study in the August issue of the Journal of AAPOS (American Association for Pediatric Ophthalmology and Strabismus). Led by Dr. R.

NicOx updates on PF-03187207 and research collaboration with Pfizer (News-Medical-Net)

NicOx S.A. has announced the results of a dose-ranging phase 2 study conducted with PF?03187207 in Japanese patients with glaucoma by its partner Pfizer Inc. PF-03187207 is a nitric oxide-donating prostaglandin analog. The study was designed to compare the safety and efficacy of several doses of PF-03187207 to Xalatan (latanoprost) and enrolled 112 Japanese patients with primary open-angle ...

Sea Lions plan free health screenings (Newport News-Times)

The Pacific Sea Lions Club is working with the Oregon Lions Sight and Hearing Foundation to provide programs that positively impact quality of life in the community through free health screenings.

Medication Slows Nearsightedness In Children (Medical News Today)

Daily treatment with pirenzepine can slow the rate of progressive myopia in children, according to an article published on August 26, 2008 in the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS). When someone is myopic, or nearsighted, he is able to focus on objects that are close to the eye but objects that are more distant appear blurry.

ADHD medication VYVANSE now available in 6 dosage strengths at US pharmacies (EurekAlert!)

( Porter Novelli ) Shire Limited, the global specialty biopharmaceutical company, announces VYVANSE is available in US pharmacies in three additional dosage strengths, bringing the total dosage strength number to six: 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 70 mg. The expanded VYVANSE dosing options allow physicians to individualize treatment for each patient. VYVANSE, which received FDA approval ...

Medication slows progression of myopia in children (EurekAlert!)

Daily treatment with a medication called pirenzepine can slow the rate of progressive myopia, or nearsightedness, in children, reports a study in the August issue of the Journal of American Association for Pediatric Ophthalmology and Strabismus.

Medication Slows Progression Of Myopia In Children (Science Daily)

Daily treatment with a medication called pirenzepine can slow the rate of progressive myopia, or nearsightedness, in children, reports a new study.

deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008

REYKJAVIK, Iceland, Aug. 28 /PRNewswire-FirstCall/ -- deCODE genetics today announced that it will host a live webcast of deCODE CSO Jeffrey Gulcher's presentation at Thomas Weisel Partners Healthcare ...

BiCOM Helps in the Fight Against Glaucoma With The Use Of Tonometer Diaton

BiCOM with its Tonometer Diaton Glaucoma Eye Test is Glad to Join Community Health Action Campaign with Free Glaucoma Screenings for a New York City borough.

Mainer's west-east bike trip aids fight against glaucoma

"One of my parents works at PVH and yes it was in lockdown. But what difference does that make? This " "Takei...today, it is raining here in the Philippines.

Interventional Ophthalmology Procedure Indicated for Treatment of Glaucoma

Patients with glaucoma have a promising new treatment option for the reduction of elevated pressure inside the eye.

Heidelberg Enhances Website Features

Heidelberg Engineering has launched its newly updated website. New and enhanced features improve the ease of information retrieval and provide enhanced clinician and operator education for all Heidelberg ...

Refractive Surgery and Glaucoma: Can It Work?

The disease isn't necessarily a contraindication for LASIK or PRK. Here's help choosing the best way to proceed.

Pfizer Inc. Cancels Phase III of Glaucoma Drug Research in Asia

Aug 25, 2008 -- NicOx S.A. today announced the results of a dose-ranging phase 2 study conducted with PF03187207 in Japanese patients with glaucoma by its partner Pfizer Inc.

Nicox Says Pfizer Drops Glaucoma Drug Study In Asia

French biotechnology firm Nicox said on Monday U.S. partner Pfizer had decided not to launch Phase III studies in Asia of an experimental treatment of glaucoma and ocular hypertension.

Taking Stock

Finance Scott Muschinske of the Wausau area received awards at a regional meeting for Edward Jones Financial Advisors.

Benefits of Walking - How Walking Reduces Health Risks

There are many health benefits of walking. Walkers have less incidence of cancer, heart disease, stroke, diabetes and other killer diseases.